The FDA announced on April 6, 2026, that Microvention Inc. is recalling LVIS Intraluminal Support Devices due to potential dimensional nonconformance and incorrect device configuration caused by manufacturing commingling. The agency issued recall number Z-2200-2026 for the Class II voluntary recall affecting products distributed internationally to China.
How to tell if you have it
- LVIS Intraluminal Support Device, REF/Outside Diameter(OD)xTotal Length(TL)xWorking Length(WL): 214022-CAS/4.0 mm x 22
- UPC 00842429115893
- UPC 00842429115930
- UPC 00842429115961
- Lot codes: 0000616462, 0000619851, 0000552987, 0000551725
The hazard
The stent-assisted coiling device may have dimensional nonconformance and/or incorrect device configuration due to commingling during manufacturing. If oversized, the device may lead to increased vessel wall stress, neointimal hyperplasia, or vessel injury/rupture; if undersized, it may cause incomplete expansion/malposition, acute stent thrombosis, distal embolization, or ischemic neurological events.
Context
GovInfoNow's records show Microvention Inc. has 15 other recalls on record since 2017-08-07. Recent brand recalls include a Bobby Balloon Guide Catheter recall for balloon pinhole defects on 2026-04-30, Flow Re-Direction Devices with incomplete deployment risks on 2025-09-05, and LIFEPEARL Drug Elutable Microspheres with ineffective treatment risks on 2025-05-29. Other recent recalls of similar products include the Micro Therapeutics Pipeline Flex Embolization Device for incorrect labeling risk on 2026-06-08, the INSPIREMD CGuard Prime Carotid Stent System for deployment complications risk on 2026-05-01, and the Bard Ureteral Stent Kit for label size mismatch risk on 2025-11-06.